Hawk Ridge Capital Management LP Has $74.99 Million Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Hawk Ridge Capital Management LP increased its stake in Acadia Healthcare by 437.5% in Q1, acquiring over 2 million shares, making it the fund's 15th largest position.
• Citigroup also significantly boosted its holdings in Acadia Healthcare by over 5,000%, now owning approximately $72 million in shares.
• Analysts have downgraded price targets for Acadia Healthcare, with a consensus target now at $40.77, amid mixed ratings from various research firms.

Hawk Ridge Capital Management LP boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 437.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,473,226 shares of the company's stock after acquiring an additional 2,013,126 shares during the period. Acadia Healthcare makes up approximately 3.5% of Hawk Ridge Capital Management LP's investment portfolio, making the stock its 15th largest holding. Hawk Ridge Capital Management LP owned 2.68% of Acadia Healthcare worth $74,988,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Adage Capital Partners GP L.L.C. lifted its holdings in Acadia Healthcare by 69.0% during the first quarter. Adage Capital Partners GP L.L.C. now owns 428,580 shares of the company's stock worth $12,995,000 after acquiring an additional 175,000 shares in the last quarter. RA Capital Management L.P. acquired a new stake in shares of Acadia Healthcare in the 1st quarter valued at about $6,579,000. Abrams Bison Investments LLC acquired a new stake in shares of Acadia Healthcare in the 1st quarter valued at about $55,182,000. 8 Knots Management LLC raised its stake in shares of Acadia Healthcare by 99.3% in the 1st quarter. 8 Knots Management LLC now owns 1,309,180 shares of the company's stock valued at $39,694,000 after purchasing an additional 652,217 shares during the period. Finally, Maverick Capital Ltd. raised its stake in shares of Acadia Healthcare by 116.3% in the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company's stock valued at $68,127,000 after purchasing an additional 1,208,296 shares during the period.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ACHC. Raymond James Financial reissued an "outperform" rating and issued a $26.00 price target (down previously from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Royal Bank Of Canada dropped their price target on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. UBS Group lowered their target price on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Finally, KeyCorp lowered their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Nine research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $40.77.

Acadia Healthcare Stock Down 5.0%

Shares of NASDAQ:ACHC traded down $1.18 during midday trading on Monday, reaching $22.54. The company had a trading volume of 2,885,977 shares, compared to its average volume of 2,219,568. The business's 50 day moving average price is $22.21 and its 200 day moving average price is $24.71. The stock has a market cap of $2.08 billion, a PE ratio of 14.93, a P/E/G ratio of 4.67 and a beta of 0.89. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $79.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business's revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.